Location · Indiana
Clinical trials recruiting in Indiana
433 recruiting studies have at least one site in Indiana; 119 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Indiana.
433 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Indianapolis, IN + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Relay Therapeutics, Inc.
- Location
- Indianapolis, IN + 21 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 1/Phase 2
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics
- Location
- Carmel, IN + 19 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Indianapolis, IN + 78 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingPhase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Amgen
- Location
- Evansville, IN + 193 other US sites
- Eligibility basics
- Ages 50–105
- RecruitingPhase 3
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Novo Nordisk A/S
- Location
- Hammond, IN + 129 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Alkermes, Inc.
- Location
- Indianapolis, IN + 14 other US sites
- Eligibility basics
- Ages 10–17
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Indianapolis, IN + 42 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2/Phase 3
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Exciva GmbH
- Location
- Indianapolis, IN + 6 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 1
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Claris Biotherapeutics, Inc.
- Location
- Carmel, IN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Mannkind Corporation
- Location
- Indianapolis, IN + 9 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
GlaxoSmithKline
- Location
- Hammond, IN + 29 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Indianapolis, IN + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Location
- Hammond, IN + 27 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Indianapolis, IN + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
Zydus Therapeutics Inc.
- Location
- Indianapolis, IN + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
GlaxoSmithKline
- Location
- Indianapolis, IN + 28 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Insulet Corporation
- Location
- Bloomington, IN + 25 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Insulet Corporation
- Location
- Indianapolis, IN + 10 other US sites
- Eligibility basics
- Ages 14–75
- RecruitingPhase 2/Phase 3
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Kyverna Therapeutics
- Location
- Indianapolis, IN + 9 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Healx Limited
- Location
- Indianapolis, IN + 13 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.
Biocomposites Ltd
- Location
- Indianapolis, IN + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
Thrombolex, Inc.
- Location
- Hobart, IN + 22 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Evansville, IN + 131 other US sites
- Eligibility basics
- Ages 65+